Search results
Found 1082 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Oxford vaccine team shortlisted for parliamentary awards
Awards and Appointments Coronavirus COVID-19 Research
24 November 2020
The University of Oxford team who have developed a COVID-19 vaccine in record time have been shortlisted for the Excellence in Healthcare Award at the NHS Parliamentary Awards.
Oxford University breakthrough on global COVID-19 vaccine
Coronavirus COVID-19 General Research
23 November 2020
The University of Oxford, in collaboration with AstraZeneca plc, today announces interim trial data from its Phase III trials that show its candidate vaccine, ChAdOx1 nCoV-2019, is effective at preventing COVID-19 (SARS-CoV-2) and offers a high level of protection.
People in prison should be prioritised for any COVID-19 vaccine
Coronavirus COVID-19 General Research
20 November 2020
Preventing serious complications from COVID-19 in potentially vulnerable populations in high risk environments, such as prisons, and preventing spread to surrounding communities needs a coordinated evidence-based approach to managing outbreaks of COVID-19 in prison settings.
Prior COVID-19 infection offers protection from re-infection for at least six months
Coronavirus COVID-19 General Research
20 November 2020
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again, for at least six months following their first infection.
Transplant kidney survival rate improves with new method of transportation
General Research
20 November 2020
New research by the Consortium for Organ Preservation in Europe (COPE) has found that a new method to transport donor kidneys, which uses a combination of cold perfusion with oxygen, can significantly improve transplant results, with less graft failure, better function and lower rejection of the kidney when compared to cold perfusion alone. For patients who need a kidney transplant this is a big step forward. The study, carried out in Belgium, The Netherlands and the UK, was published today in The Lancet.
Viruses shown to evolve as a result of different immune responses in different ethnic populations
Coronavirus COVID-19 General Research
20 November 2020
New research into the HIV-1 virus has shed light on an important factor in the evolution of viruses, which is likely also to affect SARS-CoV-2 (the virus which causes COVID-19). This new insight could have important implications for vaccine development.
Oxford coronavirus vaccine produces strong immune response in older adults
Clinical Trials Coronavirus COVID-19 General Research
19 November 2020
The ChAdOx1 nCov-2019 coronavirus vaccine, developed by teams at the University of Oxford, has been shown to trigger a robust immune response in healthy adults aged 56-69 and those over 70 years of age.
Return to school sees improvement in children's mental health
Coronavirus COVID-19 General Research
17 November 2020
Mental health difficulties in children increased during the first national lockdown (between March and June 2020), but have decreased since.
Interferon-b trial shows positive results
Clinical Trials Coronavirus COVID-19 General Research
16 November 2020
A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients.
Oxford University and PHE confirm high-sensitivity of Lateral Flow Tests following extensive clinical evaluation
Coronavirus COVID-19 General Research
12 November 2020
Extensive clinical evaluation from Public Health England and the University of Oxford show Lateral Flow Tests are accurate and sensitive enough to be used in the community, including for asymptomatic people.
Oxford ramps up COVID-19 testing capability
Coronavirus COVID-19 General Research
10 November 2020
The University of Oxford has joined forces with Thermo Fisher Scientific, the world leader in serving science, to ramp up the university’s capacity to deliver COVID-19 testing data.
HIV-1 recombinants: The challenges of increasing genetic diversity
General Research
10 November 2020
Dr Joris Hemelaar, University Research Lecturer and expert in maternal HIV infection at the Nuffield Department of Women's & Reproductive Health, published a new article: "Global and regional epidemiology of HIV-1 recombinants in 1990-2015" in the Lancet HIV.
Almost 20% of COVID-19 patients receive psychiatric diagnosis within 90 days
Coronavirus COVID-19 General Research
10 November 2020
New study suggests that having COVID-19 increases a person’s risk of developing psychiatric disorders, and that having a psychiatric disorder increases the chance of getting COVID-19. The study, published in The Lancet Psychiatry, used the TriNetX electronic health records of 69 million people in the USA including over 62,000 cases of COVID-19.
Virtual wards: caring for COVID-19 patients at home could save lives
Coronavirus COVID-19 General Research
9 November 2020
Odds and evens: a strategy for safely exiting lockdown 2
Coronavirus COVID-19 General Research
9 November 2020
COVID antibodies wane within months, healthcare workers study shows
Coronavirus COVID-19 Research
6 November 2020
Antibodies to COVID-19 fall by half in less than 90 days, and antibody levels peak lower and fall faster in younger adults, an ongoing study of staff at Oxford University Hospitals NHS Foundation Trust has revealed.
Analysis shows that funding gender equity incentives can work
Athena Swan General Research
4 November 2020
A paper by Oxford BRC-supported researchers says that linking research funding to Athena SWAN gender equality action plans has been associated with a rise in the number of women in mid-level leadership positions and the proportion of funding going to women.
New research confirms obesity is a cause of kidney disease
General Research
4 November 2020
Scientists at the University of Oxford have discovered that obesity can increase the chances of someone developing kidney disease.